Element

Fox Factory Holding Corp. Reports Fourth Quarter and Fiscal 2023 Financial Results

Retrieved on: 
Thursday, February 22, 2024

DULUTH, Ga., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”) today reported financial results for the fourth quarter and fiscal year ended December 29, 2023.

Key Points: 
  • DULUTH, Ga., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”) today reported financial results for the fourth quarter and fiscal year ended December 29, 2023.
  • Gross margin was 27.7% for the fourth quarter of fiscal 2023, a 430 basis point decrease from gross margin of 32.0% in the fourth quarter of fiscal 2022.
  • Adjusted EBITDA in the fourth quarter of fiscal 2023 was $38.8 million, compared to $76.8 million in the fourth quarter of fiscal 2022.
  • Adjusted EBITDA margin in the fourth quarter of fiscal 2023 was 11.7%, compared to 18.8% in the fourth quarter of fiscal 2022.

RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy

Retrieved on: 
Thursday, February 22, 2024

PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.

Key Points: 
  • PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.
  • The present invention relates to systems and methods for visualizing eye anatomy for diagnostic and therapeutic purposes.
  • Furthermore, it allows for the detection and analysis of various conditions of the eye, such as, hydration, innervations, inflammation, circulation, nerve conduction, etc.
  • Some of the best-studied ocular conformational diseases include cataracts in the lens and retinitis pigmentosa in the retina.

Element Fleet Management Announces New Leasing Hub in Dublin

Retrieved on: 
Thursday, February 22, 2024

TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, recently announced the creation of 70 new jobs as it establishes a centralized leasing function in Dublin, Ireland.

Key Points: 
  • TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, recently announced the creation of 70 new jobs as it establishes a centralized leasing function in Dublin, Ireland.
  • “Centralizing accountabilities for our leasing function into a global leasing centre of excellence allows us to optimize related operations, drive greater strategic focus and ultimately further elevate our clients’ leasing experience,” said Laura Dottori-Attanasio, President and Chief Executive Officer, Element Fleet Management.
  • Simon Coveney, Minister for Enterprise, Trade and Employment commented, “I warmly welcome Element Fleet Management’s commitment to create 70 jobs in Dublin.
  • Candidates interested in learning more about employment opportunities with Element Fleet Management, should visit the recruitment site .

Gordian Announces Strategic Collaboration Agreement with eTakeoff

Retrieved on: 
Wednesday, February 21, 2024

Greenville, SC, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Gordian, provider of data-driven solutions for all phases of the building lifecycle, today announced a strategic collaboration with eTakeoff, making eTakeoff's electronic takeoff software for construction estimating now available directly through Gordian's suite of offerings.

Key Points: 
  • Greenville, SC, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Gordian, provider of data-driven solutions for all phases of the building lifecycle, today announced a strategic collaboration with eTakeoff, making eTakeoff's electronic takeoff software for construction estimating now available directly through Gordian's suite of offerings.
  • This strategic collaboration provides tools to validate all three elements, allowing construction professionals to greatly increase the accuracy and efficiency of future estimates.
  • “We’re elated to be working with Gordian on this collaboration,” said Curtis Peltz, CEO of eTakeoff.
  • The collaboration is the first phase of an integration planned between eTakeoff and RSMeans Data Online for a more efficient way to accomplish cost estimating.

Patio Power Shades Launch Range of Motorized Patio Shades to Help Homeowners Enhance Their Outdoor Living Experience

Retrieved on: 
Wednesday, February 21, 2024

Frisco, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Patio Power Shades is pleased to announce the launch of its range of motorized patio shades TX that are designed to help homeowners significantly improve their outdoor living experience by serving several essential functions without the need for manual replacement.

Key Points: 
  • Frisco, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Patio Power Shades is pleased to announce the launch of its range of motorized patio shades TX that are designed to help homeowners significantly improve their outdoor living experience by serving several essential functions without the need for manual replacement.
  • The new range of motorized patio shades at Patio Power Shades offers homeowners a versatile and practical addition to any outdoor space by providing protection from the elements, privacy, and the convenience of automated control.
  • “Imagine you’re lounging on your patio, and the sun’s rays are scorching hot,” said a spokesperson for Patio Power Shades.
  • To learn more about Patio Power Shades and the launch of its range of motorized patio shades, please visit the website at www.patiopowershades.com .

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

Retrieved on: 
Wednesday, February 21, 2024

For the fourth quarter of Fiscal 2023, sales of EGRIFTA SV® reached $16,958,000 compared to $14,458,000 in the fourth quarter of the prior year, representing an increase of 17.3%.

Key Points: 
  • For the fourth quarter of Fiscal 2023, sales of EGRIFTA SV® reached $16,958,000 compared to $14,458,000 in the fourth quarter of the prior year, representing an increase of 17.3%.
  • In the fourth quarter of Fiscal 2023, Trogarzo® sales amounted to $6,494,000 compared to $6,963,000 for the same quarter of Fiscal 2022, representing a decrease of 6.7%.
  • Lower unit sales in the fourth quarter of Fiscal 2023, were also a result of higher inventory buildup in Fiscal 2022, a situation which has resolved itself in Fiscal 2023.
  • Net finance costs in the fourth quarter of Fiscal 2022 included interest on the Convertible Notes, whereas this amount was nil in the fourth quarter of Fiscal 2023.

Northrop Grumman Advances Sentinel Design Phase With Key Tests

Retrieved on: 
Tuesday, February 20, 2024

ROY, Utah, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) successfully completed tests of several crucial elements of the Sentinel intercontinental ballistic missile (ICBM), marking significant progress for the program in its engineering, manufacturing and development phase.

Key Points: 
  • ROY, Utah, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) successfully completed tests of several crucial elements of the Sentinel intercontinental ballistic missile (ICBM), marking significant progress for the program in its engineering, manufacturing and development phase.
  • The shroud fly-off and missile modal tests were part of the company’s engineering, manufacturing, and development (EMD), or design, contract for Sentinel.
  • Northrop Grumman is closely partnered with the Air Force as the EMD phase progresses and key milestones are achieved.
  • (Photo Credit: Northrop Grumman)
    Sarah Willoughby, vice president and program manager, Sentinel, Northrop Grumman: “Working with the Air Force and our team of suppliers, we put key elements of the missile’s hardware to the test to mature our design and lower risk.

NorthWest Copper Announces Appointment of Investor Relations Consultant

Retrieved on: 
Tuesday, February 20, 2024

VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce that, subject to regulatory approval, it has retained the services of David Jan Consulting (“Consultant”) to provide investor relations services at an hourly rate on a month-to-month basis effective immediately.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce that, subject to regulatory approval, it has retained the services of David Jan Consulting (“Consultant”) to provide investor relations services at an hourly rate on a month-to-month basis effective immediately.
  • The Consultant is at arm’s length to NorthWest, has no relationship with the Company except under this contract, and no current interest in the Company.
  • David Jan, CPA, CA, has over 30 years of progressively senior financial management experience with numerous natural resource public companies.
  • For the past 18 years, he has been either an in-house or external investor relations professional helping public mining companies, including Western Coal, Nevsun Resources, Entrée Resources, Ridgeline Minerals, Element 29 Resources, and Vior Inc., tell their investment story.

Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis

Retrieved on: 
Tuesday, February 20, 2024

BEDMINSTER, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces alignment with the U.S. Food and Drug Administration (FDA) on the design of a single Phase 3 registration trial of MAT2203 in patients with invasive aspergillosis who have limited treatment options (the “ORALTO” trial).

Key Points: 
  • “We are pleased to achieve alignment with the FDA on the design of a single Phase 3 trial to support the registration of MAT2203 for the treatment of invasive aspergillosis in patients with limited treatment options,” commented Dr. Theresa Matkovits, Chief Development Officer at Matinas.
  • “We greatly appreciate the opportunity to work collaboratively with the FDA, which was essential for reaching consensus on all critical elements of the registrational path for MAT2203.
  • “We are energized by the support and guidance from the FDA, and believe this alignment provides the requisite certainty to advance our partnership discussions for this important product.
  • We are pursuing every opportunity to secure a partner and to advance MAT2203 into this Phase 3 registration trial as quickly as possible.”

Parsons Wins $25 Million Transit Improvement Contract from City of Oakland

Retrieved on: 
Tuesday, February 20, 2024

This $25 million contract includes designs for eight at-grade intersections, a multiuse trail, traffic signal plans, and represents new work for Parsons.

Key Points: 
  • This $25 million contract includes designs for eight at-grade intersections, a multiuse trail, traffic signal plans, and represents new work for Parsons.
  • Parsons will also deliver feasibility studies to analyze grade separated railroad crossing features, geometric configurations and equipment upgrades.
  • Parsons has decades of experience designing, delivering, and protecting the infrastructure that connects our communities around the world, including roads and highways; bridges; passenger and freight rail; public transit; airports; and ports and waterways.
  • To learn more about Parsons’ rail and transit expertise, visit https://www.parsons.com/rail-transit/.